Home›Amoxicillin And Clavulanate Potassium›Amoxicillin And Clavulanate Potassium + Allopurinol

Does Amoxicillin And Clavulanate Potassium Interact with Allopurinol?

CDI records a moderate classification for Amoxicillin And Clavulanate Potassium and Allopurinol. The stored summary is: Concurrent administration increases incidence of rashes compared to amoxicillin alone. Mechanism unclear but may be related to allopurinol or hyperuricemia. The mechanism involves unknown; may be due to allopurinol or hyperuricemia. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Moderate
Amoxicillin And Clavulanate Potassium Class
beta Lactamase Inhibitor
Allopurinol Class
Xanthine Oxidase Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

Recorded Mechanism

Unknown; may be due to allopurinol or hyperuricemia

What To Tell Your Doctor or Pharmacist

If you are taking Amoxicillin And Clavulanate Potassium and your doctor is considering prescribing Allopurinol (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Amoxicillin And Clavulanate Potassium(Augmentin)+💊 Allopurinol(Zyloprim)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
beta Lactamase Inhibitor
Drug B class
Xanthine Oxidase Inhibitor
Source
NLP:amoxicillin and clavulanate potassium

What this means in plain English

Concurrent administration increases incidence of rashes compared to amoxicillin alone. Mechanism unclear but may be related to allopurinol or hyperuricemia.

About Amoxicillin And Clavulanate Potassium and Allopurinol

Amoxicillin And Clavulanate Potassium is a beta Lactamase Inhibitor, while Allopurinol is a Xanthine Oxidase Inhibitor. You may recognize them by the brand names Augmentin and Zyloprim. Both Amoxicillin And Clavulanate Potassium and Allopurinol carry an FDA boxed warning — the agency's most serious safety designation.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:amoxicillin and clavulanate potassium

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Amoxicillin And Clavulanate Potassium and Allopurinol against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations